Skip to content
10-Q

Quarterly Report

American CryoStem Corporation

0001019056-21-000307

← back to feed
Filed
May 17, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · May 15, 2021 60.83M sh
Capex Q2 2021 · Mar 31, 2021 $0
Capex Q2 2021 · Mar 31, 2020 $2.74K
Current Liabilities Q2 2021 · Mar 31, 2021 $1.15M
Current Liabilities Q2 2021 · Sep 30, 2020 $1.05M
Total Liabilities Q2 2021 · Mar 31, 2021 $2.28M
Total Liabilities Q2 2021 · Sep 30, 2020 $1.9M
Current Assets Q2 2021 · Mar 31, 2021 $931.86K
Current Assets Q2 2021 · Sep 30, 2020 $567.16K
Total Assets Q2 2021 · Mar 31, 2021 $1.8M
Total Assets Q2 2021 · Sep 30, 2020 $1.48M
Operating Cash Flow Q2 2021 · Mar 31, 2020 −$324.28K
Cash And Equivalents Q2 2021 · Mar 31, 2020 $11.22K
Cash And Equivalents Q2 2021 · Sep 30, 2019 $23.8K
Stockholders Equity Q2 2021 · Mar 31, 2020 −$1.48M
Stockholders Equity Q2 2021 · Dec 31, 2019 −$1.33M
Stockholders Equity Q2 2021 · Sep 30, 2019 −$1.24M
Rd Expense Q2 2021 · Mar 31, 2020 $0
Rd Expense Q2 2021 · Mar 31, 2020 $19.18K
Net Income Q2 2021 · Mar 31, 2020 −$147.23K
Net Income Q2 2021 · Mar 31, 2020 −$419.09K
Operating Income Q2 2021 · Mar 31, 2020 −$352.13K
Operating Income Q2 2021 · Mar 31, 2020 −$442.07K
Gross Profit Q2 2021 · Mar 31, 2020 $149.82K
Gross Profit Q2 2021 · Mar 31, 2020 $277.76K
Cost Of Revenue Q2 2021 · Mar 31, 2020 $11.52K
Cost Of Revenue Q2 2021 · Mar 31, 2020 $16.71K
Revenue Q2 2021 · Mar 31, 2020 $161.34K
Revenue Q2 2021 · Mar 31, 2020 $294.47K